The Tat 
are dispensable. Truncation of the RNA to 68 nucleotides results in the loss oftranslational rescue ability, s tg that the short cytoplasmic TAR RNA produced by viral trascription in vivo may not have the capability to suppress activation of the kinase. However, because longer TAR rascripts stimulate expression in a transient assay in vivo, the TAR structure at the 5' end of viral mRNAs could still exert this fumction in Cis. Human immunodeficiency virus type 1 (HIV-1) encodes several regulatory proteins essential for its replication (1, 2) . Tat is a powerful transactivator of viral gene expression that acts through an RNA element, the Tat-responsive region (TAR) located between nucleotides (nt) + 14 to +44, relative to the transcriptional start site in the long terminal repeat. TAR RNA forms a stable structure containing a stem, bulge, and loop, in which the integrity ofthe bulge and adjacent stem is important for interaction with the Tat protein. Tat interacts directly with TAR RNA to stimulate viral gene expression at the transcriptional level and possibly at posttranscriptional levels (1, 2) . TAR RNA is present at the 5' end of HIV-1 primary transcripts and mRNAs and as a cytoplasmic form of 58-66 nt (3, 4) . The stability of this short form (3) (4) (5) (6) (7) (8) suggests that it may play a role in the viral life cycle, and its apparently cytoplasmic location has prompted investigations of a translational function (9) (10) (11) (12) (13) (14) .
TAR RNA interacts with several cellular proteins, including a protein kinase, the double-stranded (ds)RNA-activated inhibitor of translation (DAI) (10) (11) (12) (13) (14) . Synthesis of this enzyme (also referred to as p68 kinase, dsI, and P1) is induced by interferon, and it is important in the cellular defense against viral infection (15) . DAI occurs in an inactive state in most mammalian cells and is activated during viral infection by dsRNA-mediated autophosphorylation. The activated enzyme phosphorylates the a subunit of eukaryotic initiation factor 2 (eIF-2) (16), which then traps another initiation factor, the guanine nucleotide exchange factor (GEF or eIF-2B). Protein synthesis is thereby blocked, and viral propagation is impaired.
Several viruses have developed ways to combat the DAImediated cellular defense mechanism (17) . Particularly relevant here are the adenovirus virus-associated (VA) RNAs and Epstein-Barr virus-encoded RNAs (EBERS), small highly structured RNAs that block the activation of DAI by dsRNA (18) . Similarly, the TAR RNA of HIV-1 can inhibit the activation of DAI by dsRNA in a kinase assay containing purified enzyme and RNA (13) . We have extended this observation to more physiological systems, both in vivo and in vitro. The rabbit reticulocyte lysate responds to a variety of physiological stimuli that regulate translation and in many ways affords a reliable representation of the in vivo situation (19) . TAR RNA blocks dsRNA-mediated inhibition of cellfree translation, indicating that it inhibits activation of DAI by dsRNA in this system. To determine the structural features of the RNA that are important for its DAI (13) . To extend these results to a more physiological setting, we examined the effect of TAR RNA on globin synthesis in the rabbit reticulocyte lysate translation system. In this system DAI is ribosome-bound (19) and probably in a more native state than the purified enzyme used in the kinase assay. The results of experiments designed to test the ability of this RNA to inhibit translation and to prevent translational inhibition by dsRNA are shown in Fig.  1 A and *To whom reprint requests should be addressed.
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TAR RNA, like VA RNA (18) , blocks the autophosphorylation of DAI by dsRNA in a direct kinase assay (13) . To examine this property in the-cell-free translation system, we tested the ability of TAR RNA to reverse the dsRNAmediated inhibition of globin synthesis in the rabbit reticulocyte lysate. The lysate was preincubated with reovirus dsRNA together with TAR RNA or VA RNA; then the remaining components were added, and translational capability was assayed by measuring globin synthesis as above. Inclusion of TAR RNA in the preincubation rescued translation to -409o of the control level (Fig. 1B, lanes 4-8) .
Similar restoration of translational capacity was obtained with adenovirus VA RNA (lanes 9-13) and with high concentrations of dsRNA (>1 Itg/ml), neither of which completely prevents DAI activation in a kinase assay (data not shown). It is unclear whether the incompleteness of the rescue is due to the preincubation protocol or to the existence of other mechanisms of inhibition by dsRNA besides DAI activation in the reticulocyte lysate translation system. Nevertheless, these data demonstrate the ability of TAR RNA and VA RNA to inhibit DAI activation in a cell-free translation system. Structral Requirements for TAR RNA Activity. DAI interacts with dsRNA and structured single-stranded RNA molecules. To define TAR RNA features that are required for its translational role, we made a variety of mutations to change its structure ( Fig. 2A) . All ofthese variant TAR RNAs were tested in the translation assay (Fig. 3) and were subjected to secondary-structure analysis (Fig. 4) . As illustrated in Fig. 4A , the S1 and BS mutants are deleted in the apical loop and at the top of the stem; mutants 3R (9) Alone, none of the RNAs inhibited protein synthesis, demonstrating that they were free of dsRNA contamination (data not shown). In the presence of dsRNA, only mutants S1 and BS were able to rescue translation. They were -60% as active as wild-type TAR RNA, whereas the remaining mutants, NF, 3R, Afl, Nhe, and RAT, were essentially inactive (Fig. 3) . The results suggested that the stem and terminal stem-loop structures are essential for DAI interaction, whereas the apical loop is dispensable. The ineffectiveness of the RAT RNA suggested that the sequence of the stem might also be important because this RNA was expected to form a structure that is the mirror-image of the TAR stem-loop. Before drawing these conclusions, however, it was necessary to examine the structures ofthe variant RNAs experimentally because it is difficult to predict RNA secondary structures from primary sequence.
To this end we used the technique of nuclease-sensitivity analysis. The mutant TAR RNAs were probed with a battery of structure-sensitive nucleases, and the cleavage sites were determined. Secondary-structure models were derived by use of a computer program that calculates the most stable structure based on thermodynamic parameters (23) , modified to incorporate the empirical data defining unpaired nucleotides. The model for wild-type TAR RNA built using this procedure closely resembles the structure predicted from sequence alone (24, 25) , except that the bulge contains 4 nt instead of 3 nt, in agreement with chemical-modification data (26) . For the mutant RNAs, however, the discrepancies were wider because the stability ofshort duplexes was exaggerated in the absence of empirical data.
The two functional mutants, S1 and BS, formed simple stem-loops. They retained a substantial part of the wild-type stem, 20 and 14 base pairs (bp), respectively. In both cases the deletion caused the formation of a larger loop differing in sequence from that in wild-type TAR RNA. The 3' terminal stem-loop structure was retained in mutant S1, but in mutant BS this sequence was essentially single stranded, suggesting that this structure is influenced by tertiary interactions with the rest of the molecule. We infer that a stem structure is important for function and that 14 bp is sufficient. The sequence of the apical loop is not critical, and neither the bulge nor the 3' terminal stem-loop is necessary for function.
The stem mutants 3R and NF exhibited disrupted stems, as expected, but maintained the wild-type apical loop. Mutant NF retained the wild-type 3' terminal stem-loop structure, whereas mutant 3R adopted a different structure, again consistent with an interaction of this region with the rest of the molecule. These mutants were inactive (Fig. 3) (Fig. 2B) . Because this RNA polymerase III promoter is intragenic, the transcribed RNA is chimeric: VA-TAR RNA is m170 nt long, containing the TAR sequence (-3 to +82) flanked by 68 nt of VA RNA sequence on its 5' side and 9 nt on its 3' end. The residual adenovirus sequences lack both the VA RNA features required for blocking DAI activation, the central domain and the apical stem (Fig. 2B) . When examined by nucleasesensitivity analysis, the regions derived from VA RNA were unstructured, as evidenced by frequent single-stranded cuts (Fig. SC) . However, the TAR RNA structure in VA-TAR was essentially identical to that in free TAR RNA. Thus, the main structure observed in the molecule was the stem and loop structure of TAR RNA together with a small 3' terminal stem-loop.
Cotransfection of pVA-TAR with the p(3CAT reporter plasmid resulted in an 8-fold stimulation of CAT enzyme activity (Fig. 5A) . In several experiments, the stimulation ranged from 3-to 9-fold. In a parallel assay VA RNA stimulated by 34-fold (range 6-to 34-fold). RNA blot analysis showed that VA RNA accumulated three to five times the level of VA-TAR RNA (Fig. SB) (10) (11) (12) 14) . To obtain synthesis of viral proteins, it was proposed that the inhibitory effect of TAR RNA is overcome either directly (12) or indirectly (35) (36) (37) whether the short TAR transcripts accumulate in the infected cell to a sufficiently high concentration to block DAI activation. On the other hand, because DAI activation can be controlled at the local level (40) (41) (42) , the possibility remains open that the TAR structure located at the 5' end of fulllength mRNAs protects HIV-1 protein synthesis against DAI activation, giving these viral mRNAs a selective advantage over cellular mRNA when dsRNA is present. The location of the TAR structure on each viral RNA would position it ideally for such a cis-acting translational role.
